WO2016205902A8 - Compositions et méthodes pour le traitement de biofilms - Google Patents

Compositions et méthodes pour le traitement de biofilms Download PDF

Info

Publication number
WO2016205902A8
WO2016205902A8 PCT/BE2016/000028 BE2016000028W WO2016205902A8 WO 2016205902 A8 WO2016205902 A8 WO 2016205902A8 BE 2016000028 W BE2016000028 W BE 2016000028W WO 2016205902 A8 WO2016205902 A8 WO 2016205902A8
Authority
WO
WIPO (PCT)
Prior art keywords
biofilms
composition
compositions
methods
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/BE2016/000028
Other languages
English (en)
Other versions
WO2016205902A3 (fr
WO2016205902A2 (fr
Inventor
Bruno Cammue
Tanne COOLS
Jan Wouter Drijfhout
Karin Thevissen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KU Leuven
Leiden University Medical Center
Original Assignee
KU Leuven
Leiden University Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1511051.3A external-priority patent/GB201511051D0/en
Priority claimed from GBGB1511447.3A external-priority patent/GB201511447D0/en
Application filed by KU Leuven, Leiden University Medical Center filed Critical KU Leuven
Publication of WO2016205902A2 publication Critical patent/WO2016205902A2/fr
Publication of WO2016205902A3 publication Critical patent/WO2016205902A3/fr
Publication of WO2016205902A8 publication Critical patent/WO2016205902A8/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Paints Or Removers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne une nouvelle composition destinée à être utilisée dans l'inhibition ou le traitement de la formation d'un biofilm microbien, ladite composition comprenant une défensine de plante ou un dérivé peptidique de celle-ci et un composé antifongique, de préférence la caspofungine, l'anidulafungine, la micafungine, ou l'amphotéricine B. Par conséquent, la présente invention concerne l'utilisation de ladite composition pour l'inhibition ou le traitement de biofilms, en particulier des biofilms fongiques, tels que des biofilms de Candida, chez un sujet ou sur une surface ou un autre milieu sensible à la formation de biofilms.
PCT/BE2016/000028 2015-06-23 2016-06-23 Compositions et méthodes pour le traitement de biofilms Ceased WO2016205902A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB1511051.3 2015-06-23
GBGB1511051.3A GB201511051D0 (en) 2015-06-23 2015-06-23 Compositions and methods for treating biofilms
GBGB1511447.3A GB201511447D0 (en) 2015-06-30 2015-06-30 Compositions and methods for treating biofilms
GB1511447.7 2015-06-30

Publications (3)

Publication Number Publication Date
WO2016205902A2 WO2016205902A2 (fr) 2016-12-29
WO2016205902A3 WO2016205902A3 (fr) 2017-02-02
WO2016205902A8 true WO2016205902A8 (fr) 2017-03-30

Family

ID=56851315

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BE2016/000028 Ceased WO2016205902A2 (fr) 2015-06-23 2016-06-23 Compositions et méthodes pour le traitement de biofilms

Country Status (1)

Country Link
WO (1) WO2016205902A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202100018530A1 (it) 2021-07-14 2023-01-14 Clever Bioscience S R L Composizioni antimicrobiche sinergiche contenenti peptidi selezionati e acidi grassi
IT202100018542A1 (it) 2021-07-14 2023-01-14 Clever Bioscience S R L Liposomi contenenti combinazioni antimicrobiche sinergiche a base di peptidi selezionati e acidi grassi

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3490201A (en) 1966-08-05 1970-01-20 Oliver D Colvin Method and apparatus for drying gases
SE335323B (fr) 1967-03-29 1971-05-24 C Munters
SE365720B (fr) 1971-08-06 1974-04-01 Atlas Copco Ab
SE368662B (fr) 1972-03-10 1974-07-15 Munters Ab Carl
US4783432A (en) 1987-04-28 1988-11-08 Pall Corporation Dryer regeneration through heat of compression and pressure swing desorption
US5683532A (en) 1990-08-12 1997-11-04 Kabushiki Kaisha Seibu Giken Method of manufacturing an active silica gel honeycomb adsorbing body usable in an atmosphere having 100% relative humidity
BE1005764A3 (nl) 1992-04-15 1994-01-18 Atlas Copco Airpower Nv Inrichting voor het drogen van een gas.
US6568100B1 (en) 1998-12-09 2003-05-27 Domnick Hunter Limited Gas dryer
AU5466400A (en) 1999-06-04 2000-12-28 Flair Corporation Rotating drum adsorber process and system
BE1013389A3 (nl) 2000-04-13 2001-12-04 Atlas Copco Airpower Nv Compressorinstallatie voorzien van een drooginrichting.
BE1013441A3 (nl) 2000-05-17 2002-01-15 Atlas Copco Airpower Nv Compressorinstallatie voorzien van een adsorptiedroger en adsorptiedroger daarvoor.
US6375722B1 (en) 2000-08-22 2002-04-23 Henderson Engineering Co., Inc. Heat of compression dryer
BE1013828A3 (nl) 2000-11-08 2002-09-03 Atlas Copco Airpower Nv Werkwijze voor het regelen van een compressorinstallatie met een droger en daarbij gebruikte compressorinstallatie.
US6957403B2 (en) 2001-03-30 2005-10-18 Syntest Technologies, Inc. Computer-aided design system to automate scan synthesis at register-transfer level
US7166149B2 (en) 2004-01-12 2007-01-23 Uop Llc Adsorption process for continuous purification of high value gas feeds
BE1016145A3 (nl) 2004-08-02 2006-04-04 Atlas Copco Airpower Nv Verbeterde compressorinrichting.
BE1016149A3 (nl) 2004-08-04 2006-04-04 Atlas Copco Airpower Nv Werkwijze voor het drogen van een gas en inrichting daarbij toegepast.
BE1016309A3 (nl) 2004-11-10 2006-07-04 Atlas Copco Airpower Nv Werkwijze voor het drogen van samengeperst gas en inrichting daarbij toegepast.
WO2007079533A1 (fr) 2006-01-10 2007-07-19 South Eastern Sydney And Illawarra Area Health Service Méthode d'établissement et de prolifération de cse humaines par culture jointe avec des cellules nourricières allogéniques dans un milieu sans sérum
EP2332631B1 (fr) 2009-12-03 2012-11-14 Kaeser Kompressoren GmbH Dispositif de séchage par adsorption ainsi que procédé de séchage par adsorption

Also Published As

Publication number Publication date
WO2016205902A3 (fr) 2017-02-02
WO2016205902A2 (fr) 2016-12-29

Similar Documents

Publication Publication Date Title
ZA202004552B (en) Microbial compositions for the prevention or reduction of growth of fungal pathogens on plants
PH12017501757A1 (en) A novel paenibacillus strain, antifungal compounds, and methods for their use
EP3903823A3 (fr) Peptides antimicrobiens et leurs procédés d'utilisation
WO2010035107A3 (fr) Peptides et compositions destinés à prévenir l'adhérence cellulaire et procédés d'utilisation de ceux-ci
MX2019007139A (es) Combinaciones de compuesto activo.
PH12018501009A1 (en) Methods for treating conditions associated with masp-2 dependent complement activation
MX2009009948A (es) Derivados de piridazinona utiles como inhibidores de glucano sintasa.
WO2014037314A3 (fr) Combinaisons de composés actifs
EP3494977A4 (fr) Composition pour prévenir ou traiter la fibrose pulmonaire comprenant comme principe actif un exosome issu de cellules souches dérivées du tissu adipeux
WO2016071438A3 (fr) Plante transgénique comprenant un polynucléotide codant un domaine variable d'anticorps à chaîne lourde
WO2014060610A3 (fr) Peptides antimicrobiens
EP3659611A4 (fr) Composition pour prévenir ou traiter l'ostéoporose contenant des exosomes extraits de cellules souches à titre de principe actif
ZA202000754B (en) Antimicrobial compositions effective against bacteria and fungus
MX2016010451A (es) Benzoxaboroles microbicidamente activos.
EP3263134A4 (fr) Composition pour la prévention ou le traitement de la calcification de valvule et contenant un inhibiteur de dpp-4
IL290304A (en) Thydic preparations for preventing or reducing the growth of fungal pathogens in plants
WO2014037315A3 (fr) Combinaisons de composés actifs
MX2011010249A (es) Metodo para combatir hongos dañinos.
DK3601393T3 (da) Coatingmaterialesammensætning, coatinger fremstillet heraf og anvendelse heraf som erosionsbeskyttelse
WO2016205902A3 (fr) Compositions et méthodes pour le traitement de biofilms
WO2012148720A3 (fr) Peptides antimicrobiennes et leurs procédés d'utilisation
WO2014106798A3 (fr) Peptides anti-microbiens, compositions les comprenant et utilisations
PH12016501448A1 (en) Antifungal composition
WO2015114633A8 (fr) Peptides se liant à l'actine et compositions les contenant pour inhiber l'angiogenèse et traiter des affections médicales associées à celle-ci
MX2016010431A (es) Composiciones para la prevencion y/o el tratamiento de patologias relacionadas con alfa-glucosidasa.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16758081

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16758081

Country of ref document: EP

Kind code of ref document: A2